Kim Jiyool

Ms. Kim Jiyool

orcid
KIST Natural Product Research

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Phytomedicine
Verified
Journal Article
Open access
YJYoungsic Jeon
Youngsic Jeon
Kim JiyoolKim Jiyool
Kim Jiyool
HKHyukjoon Kwon
Hyukjoon Kwon
YYYoung Joo Yeon
Young Joo Yeon
TKTaejung Kim
Taejung Kim
Young-Joo KimYoung-Joo Kim
Young-Joo Kim
The bioactivity and potential medicinal applications of cannabiorcol, a lesser-known derivative of Cannabis sativa, require further investigation. Osteoarthritis (OA) is a chronic joint condition marked by gradual degradation of the cartilage and commonly associated with elevated levels of matrix metalloproteinases (MMPs). However, the influence of cannabiorcol on OA and its underlying mechanisms remains unclear. In silico analysis investigated the key transcription factors that regulate MMP expression. A chondrocyte cell model [interleukin (IL)-1β and IL-1⍺-treated C20A4 cell line] was established and treated with cannabiorcol. Associated cytotoxicity was assessed using a WST-8 assay. A monoiodoacetate-induced OA rat model was established and treated with cannabiorcol. Protein translocation and transactivation analyses were conducted using immunofluorescence and dual-luciferase reporter assays, respectively. Western blotting and real-time PCR analyzed relevant markers to examine cannabiorcol's effects on OA and its fundamental mechanisms. Cannabiorcol inhibits the expression of IL-1β-induced MMPs compared to other cannabis-related compounds. In silico analysis revealed that the nuclear factor-kappa β (NF-κβ) and mitogen-activated protein kinase (MAPK) pathways are associated with MMP expression as key regulators. In vitro, cannabiorcol inhibits the NF-κB and p38 MAPK pathways independently cannabinoid receptors and transient receptor potential vanilloids. In vivo, cannabiorcol reduces MMP expression and ameliorates monoiodoacetate-induced OA traits in rats. Cannabiorcol inhibits IL-1β-induced MMP expression in vitro and alleviates OA in an MIA-induced OA rat model by reducing MMP expression and inhibiting the p65/p38 axis.

9 March 2024 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
DBDo Hyun Bae
Do Hyun Bae
HBHayeon Bae
Hayeon Bae
HYHyung‐Seok Yu
Hyung‐Seok Yu
BDBanzragch Dorjsembe
Banzragch Dorjsembe
YNYoung Hyun No
Young Hyun No
YKYong Ho Kim
Yong Ho Kim

Verified
Journal Article
Open access
PDF file
HLHara Lee
Hara Lee
SZSiqi Zhang
Siqi Zhang
HAHong Ryul Ahn
Hong Ryul Ahn
TKTaejung Kim
Taejung Kim
Kim JiyoolKim Jiyool
Kim Jiyool
JKJoonki Kim
Joonki Kim
Age-related macular degeneration (AMD) is a leading cause of vision impairment in people over the age of 60. Currently, the FDA-approved drugs for AMD have various side effects, and there is a notable lack of drug development for dry AMD. This study aimed to explore the therapeutic effects of mono-ethyl fumarate (MEF) on AMD. MEF effectively protected ARPE-19 cells from cell death induced by a combination of A2E and blue light exposure. In a C57BL/6J mouse model of retinal degeneration caused by sodium iodate, MEF played a role in preserving retinal thickness and maintaining the layered structure of the retina. It was assessed via fundus imaging, optical coherence tomography, and hematoxylin and eosin staining. Treatment with MEF significantly increased the expression of antioxidant proteins such as HO-1, NQO1, and SOD1 in ARPE-19 cells. Additionally, treatment with MEF significantly increased the levels of the antioxidant proteins SOD1 and GPX4 in the mouse retina. Concurrently, it significantly reduced the levels of apoptosis-related factors, such as the Bax/Bcl-2 ratio and Caspase -3 cleavage. These findings suggest that MEF may represent a promising therapeutic candidate for the management of AMD.

23 December 2025 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
Kim JiyoolKim Jiyool
Kim Jiyool
JKJueun Kang
Jueun Kang
YHYongseong Han
Yongseong Han
JSJinchan Sim
Jinchan Sim
YPYoung-Tae Park
Young-Tae Park
TKTaejung Kim
Taejung Kim
Concise total synthesis of N -acyl- l -phenylalanine derivatives from Micromonospora sp. MS-62 confirming S configuration by X-ray analysis.

14 January 2026 in Processes
Verified
Journal Article
Open access
PDF file
Dahae LeeDahae Lee
Dahae Lee
Kim JiyoolKim Jiyool
Kim Jiyool
JJJin-Hyoung Jeong
Jin-Hyoung Jeong
JJJaehyun Jo
Jaehyun Jo
Young-Tae ParkYoung-Tae Park
Young-Tae Park
Ki Sung  KangKi Sung Kang
Ki Sung Kang
The pharmacological effects of ginger extract from Zingiber officinale Roscoe are well-established; however, more refined extraction methods for higher-quality yields are needed. This study isolated and evaluated 6-, 8-, and 10-shogaol and 6-, 8-, and 10-gingerol from ginger extract, assessing their effects on glucose-stimulated insulin secretion (GSIS). To ensure safety, non-toxic concentrations were determined for pancreatic β-cells. Both non-processed and microwave-processed ginger extracts enhanced GSIS, with microwave-treated extracts exhibiting the strongest effect. Specifically, the microwave-processed ginger extract increased the glucose stimulation index (GSI) to 12.4 ± 0.4 at 5 μg/mL, compared to a GSI of 7.7 ± 0.2 observed for the non-processed ginger extract. Notably, fraction F4 of the microwave-processed extract demonstrated superior GSIS activity. In contrast, steam-processed ginger extract induced only a modest increase in GSI under limited exposure conditions. Furthermore, 6-shogaol emerged as a key compound, correlating with increased expression of proteins crucial for pancreatic β-cell regulation. Microwave-assisted processing notably altered the content and proportion of shogaols and gingerols, significantly impacting GSIS activity. These findings underscore the importance of extraction methods in enhancing ginger’s pharmacological potential in regulating insulin secretion and pancreatic β-cell function.